Thermo Fisher Scientific has been attracting attention, with several noteworthy developments. Its performance was highlighted during the 2024 Investors' Day, during which it underscored its steadfast growth and earnings expectations. Several reports noted solid financial prospects, with measurable improvement in Relative Price Performance. Sei Investments Co increased its holding of Thermo Fisher shares, indicating faith in its performance. Credit ratings, including Strong-Buy from UBS Group, have generally trended upward, with Stifel Nicolaus raising its price target to $680.00.
Its financial results have outperformed market expectations, with Q2 2024 earnings beating estimates. The results saw a lift in annual profit outlook, and an increase in Adjusted EPS. Thermo Fisher's stock soared 40% in 5 months. However, insiders seem cautious, selling US$2.3m of stock, even though the company declared a quarterly dividend. The impressive Return on Investment (ROI) of 113% over the past five years has won investor trust. There have also been successful acquisitions, like Olink, and innovative products introduced.
Thermo Fisher Scientific TMO News Analytics from Wed, 31 Jan 2024 08:00:00 GMT to Sat, 21 Sep 2024 13:11:25 GMT - Rating 7 - Innovation 8 - Information 6 - Rumor -3
